These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23642462)

  • 21. Predictors of relapse of psychotic depression: Findings from the STOP-PD II randomized clinical trial.
    Flint AJ; Bingham KS; Alexopoulos GS; Marino P; Mulsant BH; Neufeld NH; Rothschild AJ; Voineskos AN; Whyte EM; Meyers BS;
    J Psychiatr Res; 2023 Jan; 157():285-290. PubMed ID: 36535116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum monitoring of antipsychotic drug levels during concomitant administration of sertraline and antipsychotic medication.
    Pierson K; Addington D; Addington J; Patten S
    Can J Psychiatry; 2006 Oct; 51(11):715-8. PubMed ID: 17121171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials.
    Wagner KD; Ambrosini P; Rynn M; Wohlberg C; Yang R; Greenbaum MS; Childress A; Donnelly C; Deas D;
    JAMA; 2003 Aug; 290(8):1033-41. PubMed ID: 12941675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A gender analysis of the study of pharmacotherapy of psychotic depression (STOP-PD): gender and age as predictors of response and treatment-associated changes in body mass index and metabolic measures.
    Deligiannidis KM; Rothschild AJ; Barton BA; Kroll-Desrosiers AR; Meyers BS; Flint AJ; Whyte EM; Mulsant BH;
    J Clin Psychiatry; 2013 Oct; 74(10):1003-9. PubMed ID: 24229753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Beyond Ageing Project Phase 2--a double-blind, selective prevention, randomised, placebo-controlled trial of omega-3 fatty acids and sertraline in an older age cohort at risk for depression: study protocol for a randomized controlled trial.
    Cockayne NL; Duffy SL; Bonomally R; English A; Amminger PG; Mackinnon A; Christensen HM; Naismith SL; Hickie IB
    Trials; 2015 Jun; 16():247. PubMed ID: 26037484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of antipsychotic medication on functional connectivity in major depressive disorder with psychotic features.
    Neufeld NH; Oliver LD; Mulsant BH; Alexopoulos GS; Hoptman MJ; Tani H; Marino P; Meyers BS; Rothschild AJ; Whyte EM; Bingham KS; Flint AJ; Voineskos AN
    Mol Psychiatry; 2023 Aug; 28(8):3305-3313. PubMed ID: 37258617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishing the cut-off score for remission and severity-ranges on the Psychotic Depression Assessment Scale (PDAS).
    Østergaard SD; Rothschild AJ; Flint AJ; Mulsant BH; Whyte EM; Vermeulen T; Bech P; Meyers BS
    J Affect Disord; 2016 Jan; 190():111-114. PubMed ID: 26496016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Residual or re-emergent impaired insight into delusions following remission is unrelated to later relapse during a randomized clinical trial of continuation pharmacotherapy for psychotic depression - The STOP-PD II Study.
    Song J; Mulsant BH; Sanches M; Alexopoulos GS; Marino P; Meyers BS; Rothschild AJ; Voineskos AN; Whyte EM; Flint AJ; Gerretsen P;
    J Affect Disord; 2023 Mar; 325():29-34. PubMed ID: 36592671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sleep architecture and cognitive changes in olanzapine-treated patients with depression: a double blind randomized placebo controlled trial.
    Lazowski LK; Townsend B; Hawken ER; Jokic R; du Toit R; Milev R
    BMC Psychiatry; 2014 Jul; 14():202. PubMed ID: 25030264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study.
    Stein MB; Kline NA; Matloff JL
    Am J Psychiatry; 2002 Oct; 159(10):1777-9. PubMed ID: 12359687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of Low-dose Olanzapine in Combination with Sertraline on Negative Symptoms and Psychosocial Functioning in Schizophrenia: A Randomized Controlled Trial.
    Xiu M; Zhao L; Sun Q; Lang X
    Curr Neuropharmacol; 2024; 22(8):1406-1413. PubMed ID: 37711125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses.
    Matthews JD; Bottonari KA; Polania LM; Mischoulon D; Dording CM; Irvin R; Fava M
    J Clin Psychiatry; 2002 Dec; 63(12):1164-70. PubMed ID: 12523877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Second-generation antipsychotics for major depressive disorder and dysthymia.
    Komossa K; Depping AM; Gaudchau A; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008121. PubMed ID: 21154393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial.
    Carney RM; Freedland KE; Rubin EH; Rich MW; Steinmeyer BC; Harris WS
    JAMA; 2009 Oct; 302(15):1651-7. PubMed ID: 19843899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Impact of Sertraline Co-Administration on the Pharmacokinetics of Olanzapine: A Population Pharmacokinetic Analysis of the STOP-PD.
    Davies SJ; Mulsant BH; Flint AJ; Meyers BS; Rothschild AJ; Whyte EM; Kirshner MM; Sorisio D; Pollock BG; Bies RR
    Clin Pharmacokinet; 2015 Nov; 54(11):1161-8. PubMed ID: 25971243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative analysis of selective serotonin reuptake inhibitors and fall risk in older adults.
    Haddad YK; Kakara R; Marcum ZA
    J Am Geriatr Soc; 2022 May; 70(5):1450-1460. PubMed ID: 35132611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persisting low use of antipsychotics in the treatment of major depressive disorder with psychotic features.
    Andreescu C; Mulsant BH; Peasley-Miklus C; Rothschild AJ; Flint AJ; Heo M; Caswell M; Whyte EM; Meyers BS;
    J Clin Psychiatry; 2007 Feb; 68(2):194-200. PubMed ID: 17335316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: a double-blind, randomized trial.
    Rossini D; Serretti A; Franchini L; Mandelli L; Smeraldi E; De Ronchi D; Zanardi R
    J Clin Psychopharmacol; 2005 Oct; 25(5):471-5. PubMed ID: 16160624
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.